NDC 16714-042

Allopurinol

Allopurinol

Allopurinol is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Northstar Rxllc. The primary component is Allopurinol.

Product ID16714-042_049208c7-7904-4d26-92ac-d78d4179e3ca
NDC16714-042
Product TypeHuman Prescription Drug
Proprietary NameAllopurinol
Generic NameAllopurinol
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2009-11-16
Marketing CategoryANDA / ANDA
Application NumberANDA078253
Labeler NameNorthstar RxLLC
Substance NameALLOPURINOL
Active Ingredient Strength300 mg/1
Pharm ClassesXanthine Oxidase Inhibitor [EPC],Xanthine Oxidase Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 16714-042-07

30 TABLET in 1 BOTTLE (16714-042-07)
Marketing Start Date2009-11-16
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 16714-042-06 [16714004206]

Allopurinol TABLET
Marketing CategoryANDA
Application NumberANDA078253
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2009-11-16
Marketing End Date2015-11-26

NDC 16714-042-12 [16714004212]

Allopurinol TABLET
Marketing CategoryANDA
Application NumberANDA078253
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2013-07-19
Marketing End Date2015-11-26

NDC 16714-042-11 [16714004211]

Allopurinol TABLET
Marketing CategoryANDA
Application NumberANDA078253
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2009-11-16

NDC 16714-042-01 [16714004201]

Allopurinol TABLET
Marketing CategoryANDA
Application NumberANDA078253
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2009-11-16
Marketing End Date2015-11-26

NDC 16714-042-07 [16714004207]

Allopurinol TABLET
Marketing CategoryANDA
Application NumberANDA078253
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2009-11-16

NDC 16714-042-04 [16714004204]

Allopurinol TABLET
Marketing CategoryANDA
Application NumberANDA078253
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2009-11-16
Marketing End Date2015-11-26

NDC 16714-042-09 [16714004209]

Allopurinol TABLET
Marketing CategoryANDA
Application NumberANDA078253
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2013-07-19
Marketing End Date2015-11-26

NDC 16714-042-02 [16714004202]

Allopurinol TABLET
Marketing CategoryANDA
Application NumberANDA078253
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2009-11-16
Marketing End Date2015-11-26

NDC 16714-042-08 [16714004208]

Allopurinol TABLET
Marketing CategoryANDA
Application NumberANDA078253
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2013-07-19
Marketing End Date2015-11-26

NDC 16714-042-05 [16714004205]

Allopurinol TABLET
Marketing CategoryANDA
Application NumberANDA078253
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2009-11-16
Marketing End Date2015-11-26

NDC 16714-042-10 [16714004210]

Allopurinol TABLET
Marketing CategoryANDA
Application NumberANDA078253
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2009-11-16

NDC 16714-042-03 [16714004203]

Allopurinol TABLET
Marketing CategoryANDA
Application NumberANDA078253
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2009-11-16
Marketing End Date2015-11-26

Drug Details

Active Ingredients

IngredientStrength
ALLOPURINOL300 mg/1

OpenFDA Data

SPL SET ID:73cd79c1-6bab-4d7b-ae8b-0176efbaf5b9
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 197320
  • 197319
  • UPC Code
  • 0316714042077
  • 0316714041070
  • Pharmacological Class

    • Xanthine Oxidase Inhibitor [EPC]
    • Xanthine Oxidase Inhibitors [MoA]
    • Xanthine Oxidase Inhibitor [EPC]
    • Xanthine Oxidase Inhibitors [MoA]

    Medicade Reported Pricing

    16714004211 ALLOPURINOL 300 MG TABLET

    Pricing Unit: EA | Drug Type:

    16714004210 ALLOPURINOL 300 MG TABLET

    Pricing Unit: EA | Drug Type:

    16714004207 ALLOPURINOL 300 MG TABLET

    Pricing Unit: EA | Drug Type:

    16714004205 ALLOPURINOL 300 MG TABLET

    Pricing Unit: EA | Drug Type:

    16714004204 ALLOPURINOL 300 MG TABLET

    Pricing Unit: EA | Drug Type:

    16714004201 ALLOPURINOL 300 MG TABLET

    Pricing Unit: EA | Drug Type:

    NDC Crossover Matching brand name "Allopurinol" or generic name "Allopurinol"

    NDCBrand NameGeneric Name
    0378-0137Allopurinolallopurinol
    0378-0181Allopurinolallopurinol
    0591-5543AllopurinolAllopurinol
    0591-5544AllopurinolAllopurinol
    0603-2115Allopurinolallopurinol
    0603-2116Allopurinolallopurinol
    0615-1592AllopurinolAllopurinol
    0615-1593AllopurinolAllopurinol
    0615-8321AllopurinolAllopurinol
    0615-8385Allopurinolallopurinol
    0904-6571Allopurinolallopurinol
    0904-6572Allopurinolallopurinol
    0904-7041AllopurinolAllopurinol
    10544-545AllopurinolAllopurinol
    10544-547AllopurinolAllopurinol
    10544-911AllopurinolAllopurinol
    16571-883Allopurinolallopurinol
    16571-884Allopurinolallopurinol
    16571-885Allopurinolallopurinol
    16714-041AllopurinolAllopurinol
    16714-042AllopurinolAllopurinol
    67544-988AllopurinolAllopurinol
    68071-4131AllopurinolAllopurinol
    68788-6422AllopurinolAllopurinol
    68788-2115AllopurinolAllopurinol
    68788-0603AllopurinolAllopurinol
    68788-6323AllopurinolAllopurinol
    68788-7383AllopurinolAllopurinol
    68788-9331AllopurinolAllopurinol
    68788-9831AllopurinolAllopurinol
    68788-9832AllopurinolAllopurinol
    70518-0429AllopurinolAllopurinol
    70518-0451AllopurinolAllopurinol
    70518-0190AllopurinolAllopurinol
    70518-0476AllopurinolAllopurinol
    70518-0555AllopurinolAllopurinol
    70518-1576AllopurinolAllopurinol
    70518-1678AllopurinolAllopurinol
    70518-1407AllopurinolAllopurinol
    70518-1573AllopurinolAllopurinol
    70710-1209AllopurinolAllopurinol
    70518-1806AllopurinolAllopurinol
    70771-1127AllopurinolAllopurinol
    70710-1210AllopurinolAllopurinol
    70771-1126AllopurinolAllopurinol
    71205-049AllopurinolAllopurinol
    70934-072AllopurinolAllopurinol
    71335-0599AllopurinolAllopurinol
    71335-0112AllopurinolAllopurinol
    71335-0467AllopurinolAllopurinol

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.